Vanguard Group »

Travere Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $54M 6.6M 8.22
2024-03-31 $48M 6.3M 7.71
2023-12-31 $50M 5.5M 8.99
2023-09-30 $42M 4.7M 8.94
2023-06-30 $65M 4.2M 15.36
2023-03-31 $90M 4.0M 22.49
2022-12-31 $74M 3.5M 21.03
2022-06-30 $81M 3.3M 24.23
2022-03-31 $99M 3.8M 25.77
2021-09-30 $94M 3.9M 24.25
2021-06-30 $56M 3.8M 14.59
2021-03-31 $100M 4.0M 24.97
2020-12-31 $93M 3.4M 27.25